Unknown

Dataset Information

0

Sinopharm COVID-19 vaccine-induced Stevens-Johnson syndrome.

ABSTRACT:

SUBMITTER: Boualila L 

PROVIDER: S-EPMC8733279 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown COVID-19 vaccine-induced Stevens-Johnson syndrome.
| S-EPMC8239684 | biostudies-literature
Unknown Commercial Cannabinoid Oil-Induced Stevens-Johnson Syndrome.
| S-EPMC7053463 | biostudies-literature
Unknown The Ocular Microbiome in Stevens-Johnson Syndrome.
| S-EPMC8138458 | biostudies-literature
Unknown Amoxycillin and clavulanic acid induced Stevens-Johnson syndrome: A case report.
| S-EPMC5547378 | biostudies-other
Unknown Cheminformatics-aided pharmacovigilance: application to Stevens-Johnson Syndrome.
| S-EPMC4997030 | biostudies-literature
Unknown Lamotrigine-Valproic Acid Interaction Leading to Stevens-Johnson Syndrome.
| S-EPMC6136509 | biostudies-literature
Unknown Two Cousins with Acute Hemichorea after BBIBP-CorV (Sinopharm) COVID-19 Vaccine.
| S-EPMC9088568 | biostudies-literature
Unknown HLA-B*15:21 and carbamazepine-induced Stevens-Johnson syndrome: pooled-data and in silico analysis.
| S-EPMC5372085 | biostudies-literature
Unknown Research Directions in Genetic Predispositions to Stevens-Johnson Syndrome / Toxic Epidermal Necrolysis.
| S-EPMC5805563 | biostudies-literature
Unknown Pediatric Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States.
| S-EPMC5502094 | biostudies-literature